Filing Details
- Accession Number:
- 0001178913-22-002402
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-21 06:01:38
- Reporting Period:
- 2022-03-16
- Accepted Time:
- 2022-06-21 06:01:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534248 | Chemomab Therapeutics Ltd. | CMMB | Pharmaceutical Preparations (2834) | 813676773 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1891264 | Donald Marvin | 2094 Lost Canyon Ranch Ct Castle Rock CO 80104 | Executive Vp, Cfo & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
American Depositary Shares | Acquisiton | 2022-03-16 | 250 | $3.30 | 1,750 | No | 4 | P | Direct | |
American Depositary Shares | Acquisiton | 2022-03-16 | 250 | $3.25 | 2,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2021-11-08 | 196,875 | $0.00 | 196,875 | $9.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
196,875 | 2021-11-08 | No | 4 | A | Direct |
Footnotes
- Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- The options vest and become exercisable over a period of four (4) years, with one quarter (1/4) of the options vesting on November 8, 2022 -- the first anniversary of the grant date -- and the remainder in equal amounts over the ensuing 36 monthly periods, subject to the Reporting Person's continued service.